Bionique Testing Laboratories
Private Company
Funding information not available
Overview
Bionique Testing Laboratories is a long-established, niche CRO offering essential mycoplasma testing and validation services to biopharma clients. The company leverages over 30 years of expertise in both traditional and advanced molecular methods, including a GMP-compliant Real-Time PCR assay, to mitigate contamination risks in biologics manufacturing. It has strategically positioned itself as a critical partner for the rapidly growing cell and gene therapy sector, which demands rapid, small-volume testing solutions. Bionique operates from an FDA-registered facility in Saranac Lake, NY, and emphasizes a consultative, partnership-driven business model.
Technology Platform
Suite of mycoplasma detection methods including traditional culture-based assays, GMP-compliant Real-Time PCR (e.g., MycoSEQ), Real-Time PCR with Broth Enrichment (M-1500), and emerging Rapid Microbial Methods (RMM). Offers full assay development, validation, and transfer services.
Opportunities
Risk Factors
Competitive Landscape
Competes with other specialized microbiology testing CROs and the in-house testing capabilities of large biopharma companies. Differentiation is achieved through deep, 30+ year niche expertise, a consultative partnership model, a GMP-compliant PCR assay, and specialized solutions for advanced therapies. Larger CROs like Charles River Laboratories offer mycoplasma testing as part of a broader portfolio.